2,8-dimethoxy-5-methylphenanthridinium chloride

ID: ALA2323151

Chembl Id: CHEMBL2323151

PubChem CID: 71524055

Max Phase: Preclinical

Molecular Formula: C16H16ClNO2

Molecular Weight: 254.31

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc2c(c1)c[n+](C)c1ccc(OC)cc21.[Cl-]

Standard InChI:  InChI=1S/C16H16NO2.ClH/c1-17-10-11-8-12(18-2)4-6-14(11)15-9-13(19-3)5-7-16(15)17;/h4-10H,1-3H3;1H/q+1;/p-1

Standard InChI Key:  BNWJMOBMFSATPX-UHFFFAOYSA-M

Associated Targets(Human)

TOP1 Tclin DNA topoisomerase I (7553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TOP2A Tclin DNA topoisomerase II alpha (6317 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TOP2B Tclin DNA topoisomerase II beta (959 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DDC Tclin DOPA decarboxylase (27 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 254.31Molecular Weight (Monoisotopic): 254.1176AlogP: 2.83#Rotatable Bonds: 2
Polar Surface Area: 22.34Molecular Species: NEUTRALHBA: 2HBD:
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: -1.49CX LogD: -1.49
Aromatic Rings: 3Heavy Atoms: 19QED Weighted: 0.52Np Likeness Score: 0.43

References

1. Baechler SA, Fehr M, Habermeyer M, Hofmann A, Merz KH, Fiebig HH, Marko D, Eisenbrand G..  (2013)  Synthesis, topoisomerase-targeting activity and growth inhibition of lycobetaine analogs.,  21  (3): [PMID:23266176] [10.1016/j.bmc.2012.11.011]
2. Cheng P, Zhou J, Qing Z, Kang W, Liu S, Liu W, Xie H, Zeng J..  (2014)  Synthesis of 5-methyl phenanthridium derivatives: a new class of human DOPA decarboxylase inhibitors.,  24  (12): [PMID:24794108] [10.1016/j.bmcl.2014.04.047]

Source